NASDAQ · ENTA

Enanta Pharmaceuticals INC

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 +1
  • account_balance
    60 funds bought, 58 sold in the quarter ended Jun 30, 2026. 16 were new holders.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then. This is data, not advice.

Who owns it

124 funds report owning ENTA , down from 132

Holdings as of Jun 30, 2026
New16
Added44
Held30
Trimmed34
Sold out24

Last quarter

Who bought and who sold

Change in shares held, biggest funds first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in ENTA

As of Jun 30, 2026
FundOwnsValueChange
Jupiter Topco LLC—$53.3MNew
BlackRock, Inc.—$47.3M+5%
Krensavage Asset Management, LLC—$41.8K+0%
Farallon Capital Management, L.l.c.—$35.3M−16%
Deep Track Capital, LP—$21.1M−26%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K).

This is data, not investment advice. About StockToast